We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$2.36B
AUM Growth
+$308M
Cap. Flow
+$278M
Cap. Flow %
11.76%
Top 10 Hldgs %
35.62%
Holding
1,642
New
391
Increased
335
Reduced
424
Closed
469

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$40.9M
2
PAYX icon
Paychex
PAYX
+$30.3M
3
PFE icon
Pfizer
PFE
+$26M
4
HRB icon
H&R Block
HRB
+$24M
5
VZ icon
Verizon
VZ
+$22.9M

Sector Composition

Rank Sector Weight
1 Industrials 12.3%
2 Healthcare 11.28%
3 Technology 9.11%
4 Consumer Discretionary 8.36%
5 Financials 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUC
1151
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$49K ﹤0.01%
1,014
-644
-39% -$31.5K
RIGL icon
1152
Rigel Pharmaceuticals
RIGL
$773M
$45K ﹤0.01%
+1,169
New +$41.7K
NOR
1153
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$45K ﹤0.01%
+1,547
New +$40.8K
ANV
1154
DELISTED
Allied Nevada Gold Corp
ANV
$45K ﹤0.01%
10,387
-180,611
-95% -$905K
GEVO icon
1155
Gevo
GEVO
$403M
$44K ﹤0.01%
6
LXRX icon
1156
Lexicon Pharmaceuticals
LXRX
$1.05B
$43K ﹤0.01%
3,520
-961
-21% -$12.3K
MUX icon
1157
McEwen Inc
MUX
$1.17B
$42K ﹤0.01%
1,754
-2,998
-63% -$80.7K
NAVB
1158
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$42K ﹤0.01%
1,145
-470
-29% -$17.8K
GNK
1159
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$41K ﹤0.01%
23,493
-26,894
-53% -$51.3K
CNSY
1160
Cerenome, Inc. Common Stock
CNSY
$26.2M
0
TWGP
1161
DELISTED
TOWER GROUP INTL LTD COM STK (BERMUDA)
TWGP
$38K ﹤0.01%
14,073
-140,912
-91% -$382K
ENZN
1162
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$37K ﹤0.01%
36,398
OCLR
1163
DELISTED
Oclaro Inc.
OCLR
$36K ﹤0.01%
+11,596
New +$32.5K
GFIG
1164
DELISTED
GFI GROUP INC
GFIG
$36K ﹤0.01%
10,064
AOI
1165
DELISTED
Alliance One International
AOI
$33K ﹤0.01%
1,141
ARQL
1166
DELISTED
Arqule Inc
ARQL
$31K ﹤0.01%
15,323
-2,000
-12% -$4.48K
AMSC icon
1167
American Superconductor
AMSC
$1.54B
$29K ﹤0.01%
1,792
+550
+44% +$9.82K
BODY
1168
DELISTED
BODY CENTRAL CORP COM STK
BODY
$28K ﹤0.01%
25,900
-38,600
-60% -$117K
BGMD
1169
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
$23K ﹤0.01%
2,970
-3,941
-57% -$21.8K
LLEN
1170
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$21K ﹤0.01%
16,475
VGZ icon
1171
Vista Gold
VGZ
$331M
$6K ﹤0.01%
11,100
KIOR
1172
DELISTED
KIOR, INC CLASS A COM STK
KIOR
$6K ﹤0.01%
10,693
AAPL icon
1173
Apple
AAPL
$4.44T
-288,400
Closed -$5.78M
ABBV icon
1174
AbbVie
ABBV
$441B
-76,100
Closed -$4.02M
ABG icon
1175
Asbury Automotive
ABG
$3.77B
-6,990
Closed -$376K

Similar funds

Tudor Investment Corp's Q1 2014 Portfolio in Review

As of Q1 2014, Tudor Investment Corp held 1,642 positions worth $2.36B, up 15% from $2.05B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tudor Investment Corp deployed $278M of net new capital in Q1 2014, opening 391 new positions and adding to 335 existing holdings. Its largest new stake was Visa: 736,416 shares worth $39.7M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was LyondellBasell Industries, an estimated $95.9M trimmed.

  • Tudor Investment Corp's largest Q1 2014 buy was Visa: 736,416 shares worth $39.7M.
  • Tudor Investment Corp added most to Paychex in Q1 2014, an estimated $30.3M increase.
  • Tudor Investment Corp's biggest Q1 2014 reduction was LyondellBasell Industries, cutting an estimated $95.9M.
  • Tudor Investment Corp fully exited iShares MSCI South Korea ETF in Q1 2014, selling an estimated $162M.
  • Tudor Investment Corp's ten largest holdings make up 36% of its $2.36B portfolio in Q1 2014.
  • Tudor Investment Corp opened 391 new positions and closed 469 in Q1 2014.
  • Tudor Investment Corp's portfolio value rose 15% quarter-over-quarter to $2.36B.

Based on Tudor Investment Corp's 13F filing for Q1 2014, filed 15 May 2014.